Quest Gross Profit from 2010 to 2025

DGX Stock

USD 168.77 0.05 0.03%

Quest Diagnostics Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 2.7 B in 2025. Gross Profit is the profit Quest Diagnostics Incorporated makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

1996-09-30

Previous Quarter

811 M

Current Value

858 M

Quarterly Volatility

235.8 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 103.5 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0208 or PTB Ratio of 2.99. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.

Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Quest Diagnostics Incorporated over the last few years. Gross profit is a required income statement account that reflects total revenue of Quest Diagnostics Incorporated minus its cost of goods sold. It is profit before Quest Diagnostics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Quest Diagnostics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 3.27 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Quest Gross Profit Regression Statistics

	Arithmetic Mean	2,916,402,243
	Geometric Mean	2,753,456,389
	Coefficient Of Variation	25.34
	Mean Deviation	420,485,257
	Median	2,990,000,000
	Standard Deviation	739,026,711
	Sample Variance	546160.5T
	Range	3.6B
	R-Value	0.49
	Mean Square Error	442789.4T
	R-Squared	0.24
	Significance	0.05
	Slope	76,568,983
	Total Sum of Squares	8192407.2T

Quest Gross Profit History

	2025	2.7 B
	2024	3.2 B
	2023	3.1 B
	2022	3.4 B
	2021	4.2 B
	2020	3.6 B
	2019	2.7 B

Other Fundumenentals of Quest Diagnostics

Gross Profit Margin

Quest Diagnostics Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.86	0.29	0.94	0.99	0.87	0.39	0.79	0.87	0.97	0.66	0.97	-0.77	0.51	0.35	0.83	0.28	0.17	-0.22	0.31	0.67	0.5	-0.05
Total Stockholder Equity	0.99		0.61	0.87	0.23	0.96	0.95	0.88	0.3	0.76	0.82	0.94	0.65	0.94	-0.8	0.5	0.43	0.82	0.31	0.26	-0.31	0.33	0.63	0.54	-0.01
Net Debt	0.66	0.61		0.84	0.79	0.56	0.7	0.48	0.68	0.59	0.73	0.7	0.82	0.76	-0.61	0.51	0.0	0.73	0.38	-0.14	-0.12	0.11	0.72	0.28	-0.72
Retained Earnings	0.86	0.87	0.84		0.52	0.82	0.82	0.74	0.48	0.67	0.74	0.83	0.79	0.87	-0.89	0.52	0.37	0.82	0.53	0.24	-0.31	0.33	0.69	0.48	-0.41
Accounts Payable	0.29	0.23	0.79	0.52		0.25	0.33	0.25	0.55	0.1	0.51	0.29	0.74	0.35	-0.18	0.47	0.11	0.58	0.41	-0.29	-0.14	0.13	0.77	0.36	-0.94
Net Receivables	0.94	0.96	0.56	0.82	0.25		0.89	0.93	0.3	0.68	0.75	0.86	0.66	0.87	-0.7	0.53	0.5	0.78	0.27	0.16	-0.39	0.46	0.64	0.7	-0.03
Total Liab	0.99	0.95	0.7	0.82	0.33	0.89		0.83	0.47	0.8	0.9	0.97	0.65	0.97	-0.72	0.5	0.27	0.83	0.25	0.09	-0.13	0.27	0.69	0.46	-0.08
Total Current Assets	0.87	0.88	0.48	0.74	0.25	0.93	0.83		0.38	0.54	0.64	0.76	0.62	0.74	-0.6	0.63	0.65	0.76	0.3	0.17	-0.22	0.7	0.71	0.82	-0.04
Short Term Debt	0.39	0.3	0.68	0.48	0.55	0.3	0.47	0.38		0.26	0.52	0.35	0.5	0.42	-0.35	0.3	0.0	0.45	0.39	-0.13	0.46	0.38	0.61	0.19	-0.52
Common Stock	0.79	0.76	0.59	0.67	0.1	0.68	0.8	0.54	0.26		0.68	0.87	0.28	0.86	-0.72	0.28	-0.15	0.44	0.21	0.16	-0.11	0.04	0.22	0.11	0.02
Intangible Assets	0.87	0.82	0.73	0.74	0.51	0.75	0.9	0.64	0.52	0.68		0.87	0.63	0.89	-0.61	0.35	0.13	0.81	0.37	0.07	-0.09	0.08	0.72	0.33	-0.26
Long Term Debt	0.97	0.94	0.7	0.83	0.29	0.86	0.97	0.76	0.35	0.87	0.87		0.59	0.98	-0.77	0.45	0.19	0.8	0.26	0.18	-0.23	0.17	0.58	0.37	-0.07
Property Plant Equipment	0.66	0.65	0.82	0.79	0.74	0.66	0.65	0.62	0.5	0.28	0.63	0.59		0.67	-0.46	0.66	0.38	0.84	0.19	-0.24	-0.33	0.25	0.87	0.54	-0.62
Good Will	0.97	0.94	0.76	0.87	0.35	0.87	0.97	0.74	0.42	0.86	0.89	0.98	0.67		-0.79	0.45	0.16	0.79	0.26	0.1	-0.21	0.13	0.62	0.36	-0.15
Treasury Stock	-0.77	-0.8	-0.61	-0.89	-0.18	-0.7	-0.72	-0.6	-0.35	-0.72	-0.61	-0.77	-0.46	-0.79		-0.24	-0.3	-0.62	-0.6	-0.52	0.21	-0.25	-0.38	-0.24	0.1
Current Deferred Revenue	0.51	0.5	0.51	0.52	0.47	0.53	0.5	0.63	0.3	0.28	0.35	0.45	0.66	0.45	-0.24		0.43	0.54	0.14	-0.26	-0.06	0.46	0.68	0.58	-0.39
Net Tangible Assets	0.35	0.43	0.0	0.37	0.11	0.5	0.27	0.65	0.0	-0.15	0.13	0.19	0.38	0.16	-0.3	0.43		0.51	0.36	0.39	-0.33	0.69	0.52	0.75	0.03
Long Term Debt Total	0.83	0.82	0.73	0.82	0.58	0.78	0.83	0.76	0.45	0.44	0.81	0.8	0.84	0.79	-0.62	0.54	0.51		0.39	0.15	-0.36	0.37	0.85	0.61	-0.37
Capital Surpluse	0.28	0.31	0.38	0.53	0.41	0.27	0.25	0.3	0.39	0.21	0.37	0.26	0.19	0.26	-0.6	0.14	0.36	0.39		0.65	0.0	0.41	0.36	0.26	-0.4
Long Term Investments	0.17	0.26	-0.14	0.24	-0.29	0.16	0.09	0.17	-0.13	0.16	0.07	0.18	-0.24	0.1	-0.52	-0.26	0.39	0.15	0.65		-0.16	0.27	-0.14	0.03	0.3
Short Long Term Debt	-0.22	-0.31	-0.12	-0.31	-0.14	-0.39	-0.13	-0.22	0.46	-0.11	-0.09	-0.23	-0.33	-0.21	0.21	-0.06	-0.33	-0.36	0.0	-0.16		0.0	-0.08	-0.41	0.09
Cash And Equivalents	0.31	0.33	0.11	0.33	0.13	0.46	0.27	0.7	0.38	0.04	0.08	0.17	0.25	0.13	-0.25	0.46	0.69	0.37	0.41	0.27	0.0		0.43	0.77	-0.09
Net Invested Capital	0.67	0.63	0.72	0.69	0.77	0.64	0.69	0.71	0.61	0.22	0.72	0.58	0.87	0.62	-0.38	0.68	0.52	0.85	0.36	-0.14	-0.08	0.43		0.67	-0.57
Net Working Capital	0.5	0.54	0.28	0.48	0.36	0.7	0.46	0.82	0.19	0.11	0.33	0.37	0.54	0.36	-0.24	0.58	0.75	0.61	0.26	0.03	-0.41	0.77	0.67		-0.21
Capital Stock	-0.05	-0.01	-0.72	-0.41	-0.94	-0.03	-0.08	-0.04	-0.52	0.02	-0.26	-0.07	-0.62	-0.15	0.1	-0.39	0.03	-0.37	-0.4	0.3	0.09	-0.09	-0.57	-0.21

Click cells to compare fundamentals

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	3.2 B	2.7 B
Gross Profit Margin	0.33	0.43

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC